Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on April 25, 2025

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …

DTE Completes Construction on Pine River Solar Park

DTE Completes Construction on Pine River Solar Park

Detroit, April 25, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE:DTE), Michigan’s largest producer of and investor in renewable energy, announced that construction has been completed at Pine River Solar Park during a ribbon-cutting ceremony at the site today. …

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage …

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour   BRAF degrader demonstrates broad activity across all three BRAF mutation classes Aurora A kinase …

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings …

Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit

Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit

Hong Kong, April 25, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, the "Towards the Light: Co-creating a New Global Journey in the AI Field — 2025 AI Intelligent Development Summit" grandly opened at the Hop Hing Hotel in Hong Kong, China. This forum focused …

SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED

SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED

Corporate Rebranding Marks New Era of Engineering Excellence and Sustainable Solutions SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- SAG Holdings Limited today announced that it has changed its name to INNEOVA Holdings Limited (“INNEOVA Holdings” or the “ …

American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida

American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida

From Song to Strategy: American Rebel's CEO Andy Ross Shares the Brand's Journey with Sunshine Spotlight Host Fiona Daghir Detailing the Journey of America’s Patriotic Brand to Becoming the Next Great American Success Story. West Palm Beach, FL, April 25, …

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In recent years, SARMs have become a go-to solution for fitness enthusiasts seeking enhanced performance, lean muscle growth, and effective fat loss—without the risks associated with anabolic steroids. As …

Farm Management Canada Celebrates a Year of Partnership, Growth and Impact

Farm Management Canada Celebrates a Year of Partnership, Growth and Impact

OTTAWA, Ontario, April 25, 2025 (GLOBE NEWSWIRE) -- As Canada’s only national organization dedicated exclusively to driving farm management excellence, Farm Management Canada has worked tirelessly for over 30 years to equip farmers and industry service …

Gestion agricole du Canada célèbre une année de partenariats, de croissance et de résultats

Gestion agricole du Canada célèbre une année de partenariats, de croissance et de résultats

OTTAWA, Ontario, 25 avr. 2025 (GLOBE NEWSWIRE) -- Seule organisation nationale au Canada à se consacrer exclusivement à la promotion de l’excellence en matière de gestion agricole, Gestion agricole du Canada travaille sans relâche depuis plus de 30 ans …

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD3 at the National Bone Health …

Ov Finance Upgrades Blockchain Infrastructure to Deliver Faster, Safer Digital Asset Trading

Ov Finance Upgrades Blockchain Infrastructure to Deliver Faster, Safer Digital Asset Trading

Atlanta, GA, April 25, 2025 (GLOBE NEWSWIRE) -- Ov Finance, a financial technology and cryptocurrency company, has announced a major upgrade to its blockchain infrastructure aimed at boosting platform performance, enhancing security, and enabling seamless …

Chameleon Finance Launches Green Finance Initiative to Advance Sustainable Digital Asset Infrastructure

Chameleon Finance Launches Green Finance Initiative to Advance Sustainable Digital Asset Infrastructure

SEATTLE, WA, April 25, 2025 (GLOBE NEWSWIRE) -- Chameleon Finance, a global financial technology company, has announced the launch of a green finance initiative focused on embedding environmental sustainability into blockchain-based financial systems. This …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service